Publication profile

Education

Ms. Shahrzad Manavi Nameghi holds an M.Sc. in Molecular Biology-Genetics from Islamic Azad Tehran University of Medical Sciences, Tehran, Iran (2017–2019), where her thesis focused on the relation between rs1800437 GIPR gene and the risk of type 2 diabetes. She also earned a B.Sc. in Cellular and Molecular Biology-Genetics from Shahid Bahonar University, Kerman, Iran (2013–2017).

Work Experience and Mentorship

She has worked as a peer reviewer for the Journal of Regenerative Biology and Medicine (2020–2022) and as a main lab technician in the molecular section at Mendel Medical Genetics Laboratory, Tehran, Iran (2020–2023). Additionally, she has experience teaching biology and Arabic for college entrance exam preparation at Payandegan Science Institute (2017-2019).

Technical Skills

Her technical proficiency includes programming and software tools like R, NGS Analysis, Gene Marker, and Gene Runner. She is proficient in Microsoft Office and has strong language skills in English (IELTS 6.5) and basic German (A2.1).

Certificates and Workshops

Ms. Nameghi has participated in numerous workshops and conferences, including those focused on laboratory animals, miRNA/siRNA primer design, and essential lab skills in molecular biology.

Conclusion

Ms. Shahrzad Manavi Nameghi’s strong academic background, extensive research contributions, and practical laboratory experience make her a highly suitable candidate for the Research for Women Researcher Award. Her dedication to advancing knowledge in molecular biology and genetics, particularly in the context of diabetes and cancer research, exemplifies the qualities recognized by this award.

Publication Top Notes

Unraveling the molecular genetic basis of type 2 diabetes

Association of GIPR gene variant on the risk of type 2 diabetes mellitus: A case-control study

Dr. Chenxia Juan | Gene transcriptional regulation | Best Researcher Award

👩‍⚕️ Dr. Chenxia Juan is a distinguished researcher with a rich academic journey in gene transcriptional regulation. 🧬 From completing a seven-year master’s program in Clinical Medicine at Shandong University’s School of Medicine to earning a Doctor of Medicine from Nanjing Medical University, her expertise spans over a decade. 🏥 Dr. Juan’s contributions to nephrology were significant during her tenure at the Institute of Kidney Disease and the Provincial Hospital of Jiangsu Province. 🌐 She currently serves as an Associate Chief Physician at the Affiliated Hospital of Nanjing University of Chinese Medicine, coupled with a role as a Lecturer at Nanjing University of Chinese Medicine. 🎓 Her outstanding work has been recognized through prestigious awards and grants, including the National Natural Science Foundation of China. 🏆💼

Profile:

Scopus

Education:

👩‍⚕️ Dr. Chenxia Juan embarked on her academic journey at the School of Medicine, Shandong University, earning a seven-year master’s in Clinical Medicine from 2002 to 2009. 🎓 Her expertise in medicine expanded during her tenure at the Institute of Kidney Disease, Eastern Theater Command General Hospital (formerly Nanjing Military Region General Hospital) from July 2009 to October 2012. 💼 Specializing in nephrology, she played a vital role in healthcare. 🏥 Dr. Juan’s dedication to medical research and patient care during these formative years laid the foundation for her impactful contributions in the field. 🔬💉

Experience:

🏥 Dr. Chenxia Juan continued her impactful journey in nephrology, serving at the Department of Nephrology, Provincial Hospital of Jiangsu Province from January 2013 to August 2016. 🌐 Her commitment to advancing medical knowledge led her to pursue a Doctor of Medicine at Nanjing Medical University from September 2016 to June 2019. 🎓 Dr. Juan further diversified her expertise, contributing to children’s mental health research at the Brain Hospital affiliated with Nanjing Medical University. 🧠💡 Currently, she holds the esteemed position of Associate Chief Physician at the Affiliated Hospital of Nanjing University of Chinese Medicine, concurrently serving as a Lecturer at Nanjing University of Chinese Medicine since January 2021. 👩‍⚕️👩‍🏫

Scientific Research Project:

🏆 Dr. Chenxia Juan’s illustrious career is adorned with prestigious recognitions, showcasing her outstanding contributions to medical research. In 2021, she received support from the National Natural Science Foundation of China, highlighting her impactful work. 🇨🇳 The 2020 Nanjing Special Fund for Health Science and Technology Development further acknowledges her commitment to advancing healthcare in the region. 💉 Dr. Juan’s research excellence was previously recognized in 2019 by the National Natural Science Foundation of China and in 2017 through the Jiangsu Graduate Research and Practice Innovation Program Project. 🎓 Her early achievements include participation in the “Six Talent Peaks” project in Jiangsu Province in 2013, marking the beginning of her impactful research journey. 🌟

Publication:

“Inhibition of IGF2BP1 Attenuates Renal Injury and Inflammation by Alleviating m6A Modifications and E2F1/MIF Pathway”
- Year: 2023
- Authors: Mao, Y., Jiang, F., Xu, X.-J., …, Juan, C.-X., Zhou, G.-P.
- Journal: International Journal of Biological Sciences
- Citations: 7
- 📖🔬
“Computational Detection of a Genome Instability-Derived lncRNA Signature for Predicting the Clinical Outcome of Lung Adenocarcinoma”
- Year: 2022
- Authors: Guo, C.-R., Mao, Y., Jiang, F., …, Zhou, G.-P., Li, N.
- Journal: Cancer Medicine
- Citations: 14
- 📖🔬
“Knocking Down ETS Proto-oncogene 1 (ETS1) Alleviates the Pyroptosis of Renal Tubular Epithelial Cells in Patients with Acute Kidney Injury by Regulating the NLR Family Pyrin Domain Containing 3 (NLRP3) Transcription”
- Year: 2022
- Authors: Juan, C., Zhu, Y., Chen, Y., …, Wang, X., Wang, Q.
- Journal: Bioengineered
- Citations: 3
- 📖🔬
“Exosome-Mediated Pyroptosis of miR-93-TXNIP-NLRP3 Leads to Functional Difference Between M1 and M2 Macrophages in Sepsis-Induced Acute Kidney Injury”
- Year: 2021
- Authors: Juan, C.-X., Mao, Y., Cao, Q., …, Zhou, G.-P., Jin, R.
- Journal: Journal of Cellular and Molecular Medicine
- Citations: 49
- 📖🔬
“Long Non-Coding RNA MALAT1 Targeting STING Transcription Promotes Bronchopulmonary Dysplasia Through Regulation of CREB”
- Year: 2020
- Authors: Chen, J.-H., Feng, D.-D., Chen, Y.-F., …, Liu, S., Zhou, G.-P.
- Journal: Journal of Cellular and Molecular Medicine
- Citations: 15
- 📖🔬
“Identification of Novel lncRNAs Involved in the Pathogenesis of Childhood Acute Lymphoblastic Leukemia”
- Year: 2019
- Authors: Li, S., Bian, H., Cao, Y., …, Zhou, G., Fang, Y.
- Journal: Oncology Letters
- Citations: 17
- 📖🔬
“MicroRNA 34b Inhibits Cell Proliferation in Pediatric Acute Myeloid Leukemia via Regulating LDHA”
- Year: 2019
- Authors: Qi, H.-X., Cao, Q., Zhou, G.-P., …, Li, S., Kuai, W.-X.
- Journal: European Review for Medical and Pharmacological Sciences
- Citations: 2
- 📖🔬
“Attenuating the Abnormally High Expression of AEBP1 Suppresses the Pathogenesis of Childhood Acute Lymphoblastic Leukemia via p53-Dependent Signaling Pathway”
- Year: 2019
- Authors: Li, S., Juan, C.-X., Feng, A.-M., …, Cao, Q., Zhou, G.-P.
- Journal: European Review for Medical and Pharmacological Sciences
- Citations: 6
- 📖🔬
“Knockdown of LncRNA MALAT1 Contributes to Cell Apoptosis via Regulating NF-κB/CD80 Axis in Neonatal Respiratory Distress Syndrome”
- Year: 2018
- Authors: Juan, C., Wang, Q., Mao, Y., …, Zhang, D., Zhou, G.
- Journal: International Journal of Biochemistry and Cell Biology
- Citations: 16
- 📖🔬

Shahrzad manavi nameghi | Molecular genetics | Women Researcher Award

Ms. Shahrzad manavi nameghi | Molecular genetics | Women Researcher Award

Publication profile